HomeInsightsResults

Mankind Pharma Ltd Quarterly Result

Mankind Pharma Ltd Quarterly Result

stocks purchased

₹ 4.4 Cr

Volume Transacted

(Dec 20, 2024)

stocks purchased

15.5 K

Stocks Traded

(Dec 20, 2024)

Last Updated on: Dec 23, 2024

Image

Mankind Pharma Ltd

NSE: MANKIND

Net Profit

₹ 658.88

Last updated on: Dec 23, 2024

Key Highlights

  • The revenue of Mankind Pharma Ltd for the Sep '24 is ₹ 3188 crore as compare to the Jun '24 revenue of ₹ 2997 crore. This represent the growth of 6.3570557%.
  • The ebitda of Mankind Pharma Ltd for the Sep '24 is ₹ 962.04 crore as compare to the Jun '24 ebitda of ₹ 786.27 crore. This represent the growth of 22.35491%.
  • The net profit of Mankind Pharma Ltd for the Sep '24 is ₹ 658.88 crore as compare to the Jun '24 net profit of ₹ 543.07 crore. This represent the growth of 21.32506%.

Results Analysis

Market Price of Mankind Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Mankind Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Dec 20242803.45
19 Dec 20242889.45
18 Dec 20242805.55
17 Dec 20242661.2
16 Dec 20242690.8
13 Dec 20242640.3
12 Dec 20242650.55
11 Dec 20242623.1
10 Dec 20242668.75
09 Dec 20242640.05

Historical Revenue of Mankind Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Mankind Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Mankind Pharma Ltd

No data available

* All values are in crore

Mankind Pharma Ltd News Hub

News

Mankind Pharma allots 1.19 cr equity shares under QIP issue

Mankind Pharma has allotted 1,19,04,761 equity shares of face value of Re 1 each to the el...

Read more

20 Dec 2024 14:17

News

Mankind Pharma raises nearly Rs 3,000 crore from eligible institutional buyers via QIP issue

The company has approved the allocation of 1,19,04,761 equity shares at an issue price of ...

Read more

20 Dec 2024 11:52

News

Mankind Pharma edges higher after board approves opening of Rs 3,000 crore QIP issue

The company's board authorized and declared the opening of the issue on Monday, 16 Decembe...

Read more

17 Dec 2024 10:07

News

Mankind Pharma Ltd rises for third consecutive session

Mankind Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 2...

Read more

02 Dec 2024 13:05

News

Mankind Pharma Ltd slips for fifth straight session

Mankind Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs ...

Read more

13 Nov 2024 13:14

News

Mankind Pharma receives reaffirmation in credit rating from CRISIL

Mankind Pharma has received reaffirmation in credit ratings from CRISIL as under: Commerci...

Read more

06 Nov 2024 13:15

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

July 2024

PPT

Jan 2024

PPT

June 2023

TranscriptPPT

FAQs for Quarterly Results of Mankind Pharma Ltd

What key financial metrics are included in Mankind Pharma Ltd's quarterly results?

Key financial metrics in Mankind Pharma Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Mankind Pharma Ltd announce its quarterly results?

Mankind Pharma Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Mankind Pharma Ltd's quarterly performance impact its stock price?

Mankind Pharma Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Mankind Pharma Ltd's quarterly results on dividends?

The impact of Mankind Pharma Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Mankind Pharma Ltd's quarterly results?

Yes, Mankind Pharma Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions